- Respironics was founded by Jerry McGinnis in 1976.
- Respironics expanded manufacturing operations overseas in 1982.
- Respironics released the world’s first commercially available Continuous Positive Airway Pressure (CPAP) device in 1985.
- In 1988, Respironics makes debut on NASDAQ stock exchange under the stock symbol RESP. The Company is publicly owned and traded.
- Respironics released the first Bi-level Continuous Positive Airway Pressure (BiPAP) device in 1989.
- Forbes Magazine names Respironics one of America’s best small companies in 1990.
- In 1992, Respironics receives the U.S. patent for bi-level technology.
- In 1997, Respironics expanded its International presence, opening an office in France.
- Technological firsts include the REMstar Pro 2 with C-Flex, Encore SmartCard Data Management System, BiliChek Noninvasive Bilirubin Analyzer, BiFlex Technology, BiPAP Vision Ventilatory Support System, Adaptive Aerosol Delivery, Digital AutoTrak Sensitivity.
|
|
|